Raut, Chandrajit P <br/><br/>
Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.  [electronic resource] 

 -  Cancer biology & therapy  Dec 2004 
 - 1217-24 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-4047 
<br/><br/><label>Standard No.: </label>10.4161/cbt.3.12.1221  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--blood supply<br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Apoptosis--drug effects<br/>Celecoxib<br/>Cyclooxygenase 2<br/>Cyclooxygenase 2 Inhibitors<br/>Cyclooxygenase Inhibitors--therapeutic use<br/>Dinoprostone--metabolism<br/>Endothelial Cells--metabolism<br/>Fibroblast Growth Factor 2--metabolism<br/>Group IV Phospholipases A2<br/>Humans<br/>Indomethacin--therapeutic use<br/>Interleukin-8--metabolism<br/>Male<br/>Membrane Proteins<br/>Mice<br/>Mice, Nude<br/>Neovascularization, Pathologic--drug therapy<br/>Pancreatic Neoplasms--blood supply<br/>Phospholipases A--metabolism<br/>Phospholipases A2<br/>Prostaglandin-Endoperoxide Synthases--metabolism<br/>Pyrazoles--therapeutic use<br/>Sulfonamides--therapeutic use<br/>Tumor Cells, Cultured<br/>Vascular Endothelial Growth Factor A--metabolism<br/>Xenograft Model Antitumor Assays